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Summary 
Neurexins, a family of cell surface proteins specific 
to brain, are transcribed from two promoters in three 
genes, resulting in three a- and three I~-neurexins. In 
situ hybridization revealed differential but overlapping 
distributions of neurexin isoforms in different classes 
of neurons. PCRs demonstrated that a-neurexins are 
alternatively spliced at five canonical positions, and 
I~-neurexins at two. Characterization of many indepen- 
dent bovine neurexin la cDNAs suggests that different 
splice sites are used independently. This creates the 
potential to express more than 1000 distinct neurexin 
proteins in brain. The splicing pattern is conserved in 
rat and cow. Thus, in addition to somatic gene re- 
arrangements (immunoglobulins and T cell receptors) 
and large gene families (odorant receptors), alterna- 
tive splicing potentially represents a third mechanism 
for creating a large number of cell surface receptors 
that are expressed by specific subsets of cells. 
Introduction 
Neurexins represent a family of cell surface proteins that 
are exclusively expressed in brain (Ushkaryov et al., 1992; 
Ushkaryov and SLidhof, 1993; Geppert et al., 1992). There 
are at least six principal neurexins that are transcribed 
from three genes (designated I, II, and III). Each neurexin 
gene contains two independent promoters. The proteins 
encoded by the longer mRNAs are referred to as a-neu- 
rexins, and the ones encoded by shorter mRNAs as 
13-neurexins. c~- and 13-neurexins have distinct domain 
structures (Figure 1). (~-Neurexins contain a classic N-ter- 
minal signal sequence followed by three copies of a long 
repeat. Each repeat is comprised of a central epidermal 
growth factor (EGF)-Iike domain flanked by right and left 
arms (AA, AB, BA, Be, CA, and CB in Figure 1). These arms 
are weakly homologous to each other and to sequences 
found in a variety of extracellular matrix proteins such as 
laminin A and agrin. After the three overall repeats, (x-neu- 
rexins contain an O-linked sugar domain, a single trans- 
membrane region, and a short cytoplasmic tail. The 13-neu- 
rexins exhibit an N-terminal sequence that contains an 
atypical cleaved signal peptide followed by a short se- 
quence unique to 13-neurexins (Ushkaryov et al., 1994). The 
~-neurexins then splice into the c~-neurexin sequences at 
*Present address: Biochemistry Department, Imperial College of 
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the end of the EG F domain in the middle of the third repeat 
and have C-terminal halves identical to those of the a-neu- 
rexins (Figure 1). 13-Neurexins can be considered as 
N-terminally truncated a-neurexins that contain only 35- 
43 amino acids unique to 13-neurexins as compared with 
~-neurexins. 
The domain structure of neurexins resembles that of a 
cell surface receptor. The first neurexin (h~) was originally 
identified as the high molecular weight component of the 
receptor for a presynaptic neurotoxin, (~-Iatrotoxin (Pe- 
trenko et al., 1993). The localization of the ~-Iatrotoxin 
receptor to the presynaptic plasma membrane as well as 
immunocytochemical localization of neurexin I to syn- 
apses suggests that neurexins are synaptic proteins (Ush- 
karyov et al., 1992). The receptor-like structu re of the neu- 
rexins and their homologies with extracellular matrix 
proteins involved in the development of the nervous sys- 
tem have raised the possibility that the neurexins function 
in mediating cell-cell interactions in the nervous system. 
One of the most striking characteristics of the neurexins 
is their extensive alternative splicing. All three neurexin 
transcripts are alternatively spliced at multiple positions 
(Ushkaryov et al., 1992). Alignment of the sequences of 
the neurexins and their splice site positions reveals five 
alternative splice sites that are observed in at least two 
neurexins (labeled 1-5 in Figure 1). Extensive alternative 
splicing could theoretically generate hundreds and even 
thousands of receptor proteins that might impart different 
properties on the cells displaying these receptors. Recep- 
tor diversity is a mechanism to generate specificity in the 
immune system and in odorant perception (Tonegawa, 
1983; Buck and Axel, 1991). However, in these cases di- 
versity is not generated by alternative splicing but by gene 
rearrangements and the presence of large gene families, 
respectively. Although extensive alternative splicing has 
been observed for a number of proteins, most. of these 
are intracellular proteins with fewer than 100 variants. 
To determine whether neurexins could constitute a pro- 
tein family in which alternative splicing generates a degree 
of diversity similar to that in other recognition processes 
(e.g., more than 1000 forms), we have now studied the 
distribution of neurexin isoforms and the pattern of alterna- 
tive splicing. Previous studies demonstrated that neurex- 
ins are brain specific and extensively alternatively spliced 
but raised several questions. Are the different alternatively 
spliced sequences independent of each other? Is alterna- 
tive splicing evolutionarily conserved? Is alternative splic- 
ing stochastic or regulated; e.g., is there a region-specific 
expression of splice variants in brain? Are different neurex- 
ins subject to alternative splicing at the same position, 
and do they have similar sequence variants? Are different 
neurexins and their splice variants homogeneously or dif- 
ferentially expressed in brain? Most importantly, how 
many different splice variants are there for each site, and 
how many different neurexins are there? In the current 
study, we have tried to answer these questions in a sys- 
tematic study of the distribution and alternative splicing 
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Figure 1. Generic Domain Model of Neurexins and Locations of Differ- 
entially Spliced Sequences 
a-Neurexins contain a signal peptide (SP) followed by three overall 
repeats (A, B, and C), each of which consists of a central EGF domain 
(EGF) flanked by left and right arms (AA, AB, BA, Bs, CA, and CB). 
~-Neurexins also start with a signal peptide (SP) followed by a short 
~-specific sequence, after which they splice into the ~x-neurexins at 
the end of the third EGF domain so that they only contain the right 
arm of the third overall repeat (CB). The repeats are followed by a 
serine- and threonine-rich sequence that presumably represents an 
O-linked sugar domain (CHO). All neurexins except for some splice 
variants of neurexin III are anchored in the membrane by a transmem- 
brane region (TMR) and end in a short cytoplasmic tail. The locations 
at which at least two neurexins are alternatively spliced are indicated 
by an arrow above the diagram and referred to as alternatively spliced 
sequences 1-5. 
of the neurexins. Our data demonstrate that neurexins are 
among the most polymorphic proteins known, supporting 
their potential function as neural recognition molecules. 
Results 
Differential Expression of Neurexins 
There are six principal neurexin mRNAs transcribed from 
two promoters in three genes. The domain structures of 
the neurexins are diagrammed in Figure 1. Expression of 
multiple isoforms of a protein often serves as an evolution- 
ary mechanism of diversification. Thus, the question 
arises whether different neurexins are expressed in a com- 
plementary manner (i.e., cells only express one or the 
other neurexin isoform, similar to the exclusive expression 
of odorant receptors in olfactory neurons [Chess et al., 
1994]), or whether different neurexins are expressed in a 
combinatorial manner (i.e., neurons express distinct com- 
binations of neurexins characteristic for a given type). In 
the first case, neurons could be classified into six catego- 
ries according to which neurexin they express, and the 
six classes would be coordinately regulated via their pro- 
moters. In the second case, functionally distinct isoforms 
could be coexpressed in variable patterns in neurons to 
confer specific properties onto expressing cells, and neu- 
rons could have a large number of potential expression 
patterns dependent on the ratio of expression of different 
neurexins. To determine whether neurexin isoforms are 
coexpressed in neurons or whether a given neuron ex- 
presses only a single form, we studied the localization of 
their mRNAs by in situ hybridization. 
Rat brain sections were hybridized with oligonucleotides 
specific for the six individual neurexins and for synapsins 
as a neuronal marker (Figure 2). Control hybridizations 
were performed for all probes in the presence of a 50-fold 
excess of unlabeled oligonucleotide (shown for neurexin 
la in Figure 2). In addition, hybridization patterns with 
sense oligonucleotides or with multiple independent anti- 
sense probes for some neurexins were examined (data 
not shown). Film autoradiograms of horizontal sections 
reveal a striking differential expression of neurexins in 
brain with an exclusively neuronal expression pattern 
(Figure 2). 
Neurexin I~ is expressed in all brain regionS, with the 
highest levels in the claustrum and thalamic nuclei. In con- 
trast, neurexin 113 is restricted to a few brain areas, such 
as selected outer layers of the cerebral cortex (layers 2 and 
3), the thalamus, and parts of the hippocampal formation 
(Figure 2; see also Figure 3 and Figure 4, below). Neurexin 
I1~ expression also exhibits an interesting cortical distribu- 
tion. Neurons in three cortical layers are preferentially la- 
beled that were identified by emulsion autoradiography 
as neuronal subpopulations in layers 2, 4, and 6 (Figure 
2 and data not shown). Significant levels of neurexin Ila 
mRNAs were also detected in the thalamus and cerebel- 
lum. Neurexin 1113 was more uniformly expressed than I1(~, 
with particularly high levels in the outer layers of the cere- 
bral cortex and the cerebellum. Neurexin II1~ probes re- 
vealed a generally low signal in most brain areas. A thin 
outer layer and the inner layers of the cerebral cortex were 
labeled more strongly than the middle layers, and the stria- 
turn, septal nuclei, and reticular thalamic nucleus (RN) 
were more prominent han the remaining areas of the cen- 
tral gray matter. Neurexin 11113 transcripts were found abun- 
dantly in all brain structures without any marked regional 
preference. Studies on other brain regions such as the 
peripheral nervous system and the spinal cord also re- 
vealed a differential expression of neurexin subtypes in 
these structures (data not shown). 
Expression of Neurexins in 
the Hippocampal Formation 
Two brain regions, the hippocampal formation and the 
olfactory bulb, were chosen for in-depth studies to probe 
the combinatorial multiplicity of neurexins in neurons. The 
hippocampus, one of the best studied structures of the 
brain, consists of a limited number of types of neurons that 
are organized in a distinctive manner. This organization 
allows an unequivocal assignment of hybridization pat- 
terns at the cellular level (Figure 3). Hybridization patterns 
obtained with oligonucleotides pecific for synapsins and 
for all neurexins ("pan-neurexin") reveal an identical uni- 
form labeling of all cell types, suggesting that neurexins 
are coexpressed with synapsins in all neurons. Hybridiza- 
tions with oligonucleotides pecific for individual neurex- 
ins demonstrate slightly to dramatically different expres- 
sion patterns for the individual neurexins. As observed for 
total brain in film autoradiograms (Figure 2), neurexins I(x, 
Ila, 116, and 11113 are present in all types of neurons but 
exhibit distinct differences in expression intensity (e.g., 
note the relatively higher levels of 1113 in CA1 or of 111113 
in interneurons). In contrast, neurexins I[~ and IIl(x show 
dramatic differences in expression. Pyramidal cells and 
interneurons of CA1 contain no detectable neurexin 113 
(Figure 3, arrowheads). CA1 pyramidal cells and dentate 
gyrus granule cells lack neurexin Ilia, but the interneurons 
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Figure 2. Differential Expression f Net, rexins in Rat Brain 
Oligonucleotides specific for the indicated neurexins (Nhz to NIII6) and for synapsins as a neuronal marker (SYN) were hybridized to horizontal 
sections from adult rat brain. The distribution of neurexin I~ is similar to that of synapsins, except for an enhanced signal in the claustrum, anterior 
thalamic nuclei (M HB, medial habenular thalamic nuclei; AV, antercventral thalamic nucleus), and deep cerebellar nuclei. As a control for specificity, 
competition experiments were performed with a 50-fold excess of unlabeled oligonucleotide, which eliminates the signal (shown for neurexin le 
in NI~ comp.). Neurexin 113 shows a prominent differential distribution with intense labeling of cortical layers 2 and 3, the thalamus, and the cerebellar 
granule cell layer. Neurexin I1~ is differentially distributed among cortical layers with intense signal in layers 2, 4, and 6. Signal is also enhanced 
in the septal nuclei (SN), the reticular thalamic nucleus (RN), and some nuclei of the midbrain. For neurexin 116, an almost even hybridization is 
evident within the cortex, with slight ent"ancement in layer 2 and in the septal nuclei. Neurexin Ilia shows a prominent differential distribution: in 
the cerebral cortex, the signal is most intense in layer 6 and also detectable in layer 2. Relative to their cell density, the striatum, septal nuclei, 
and reticular thalamic nucleus are strongly labeled. In the cerebellum, an "inverted" hybridization pattern is ev dent compared with the other 
neurexins: intense labeling of the molecular nd Purkinje cell layer contrasts with very low signal in the granule cell layer. In contrast, neurexin 
1116 is evenly expressed in most brain structures and only slightly more pronounced in the anterior and medial thalamic nuclei. In competition 
controls, the slight binding of this particular probe to white matter was shown to be nonspecific. Film autoradiographs have not been digitized. 
Exposure times were 3 days to 5 weeks. 
in the same regions are strongly labeled. Thus, pyramidal 
cells of CA3 coexpress all six neurexin isoforms, whereas 
dentate gyrus granule cells selectively lack neurexin Ill~, 
and CA1 pyramidal cells lack neurexins 113 and II1~. In- 
terneurons express variable ratios of neurexins in different 
regions, with neurexin Ilia being the most prominent in all 
interneurons (Figure 3). 
Neurexins in Olfactory Bulb Neurons 
Neurons are also organized in distinct, easi ly recognizable 
layers in the olfactory bulb, allowing an unequivocal  identi- 
fication of cell types (Figure 4a) (Shepherd, 1990). Synap- 
sins are uniformly expressed in all neurons in the olfactory 
bulb (b). Hybridization of olfactory bulb sections with oligo- 
nucleotides that react with all neurexin mRNAs reveals 
the presence of neurexins in all neurons (as in all other 
brain regions examined) but very high expression levels 
in mitral and tufted cells (c). This suggests that neurexins 
are expressed particularly strongly by mitral cells, proba- 
bly because of the high levels of neurexin 113 expression 
in these cells (see below). 
Examination of the distribution of individual neurexins 
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Figure 3. Distribution ofNeurexins in the Hip- 
pocampal Formation 
Emulsion autoradiography of rat brain sections 
hybridized with oligonucleotides that are spe- 
cific for mRNAs encoding synapsin (SYN), all 
neurexins (PAN-N), or specific neurexin iso- 
forms (NI~ to NIII~). Note the differential distri- 
bution of individual neurexins in different seg- 
ments of the hippocampal formation, e.g., the 
lack of neurexin 16 and Ilia expression in CA1 
(arrowheads in NIle) and the presence of all 
neurexins in the dentate gyrus (DG) except for 
neurexin II1~ (thick arrows in NIII~). Dentate 
gyrus interneurons express high levels of neu- 
rexin Ilia (curved arrow in NIIhz). The thin 
arrows in Nla, Nlla, NIIl<z, and NIII~ point to 
interneurons in CAl. Panels show dark-field 
photographs of sections coated with photo- 
graphic emulsion and developed after 1-3 
months. 
in olfactory bulb neurons demonstrates that each neurexin 
isoform is expressed in a different pattern. Neurexin I~ is 
present at highest levels in periglomerular cells, but almost 
absent from tufted and mitral cells (Figure 4d). In contrast, 
neurexin I~ is highly expressed in mitral and tufted cells 
(e); this pattern is specific since it can be competed off 
by a 50-fold excess of oligonucleotide (f). Neurexin Ila is 
only very weakly expressed in olfactory bulb neurons (g), 
whereas neurexin 1113 is highly expressed, in particular in 
the inhibitory periglomerular nd granule cells (h). Neurex- 
ins II1~ and 11113 are both present in granule cells, but only 
neurexin 11113 exhibits significant levels in periglomerular 
cells (j and k, respectively). Thus, for the four types of 
neurons of the olfactory bulb, each type expresses a differ- 
ent combination of neurexins and is identifiable by the 
combination it expresses. 
The results of the studies on the distributions of neurex- 
ins allow several conclusions, the major being that neurex- 
ins are expressed in a differential pattern specific for each 
form. It seems likely that all neurons coexpress multiple 
neurexins, but in different combinations and ratios. ~- and 
13-neurexins are expressed independently of each other, 
although they are transcribed from the same gene, sug- 
gesting a rationale for two independent promoters. 
Neurexin I~: Splicing Patterns in 
Bovine Brain cDNAs 
In addition to the multiplicity of neurexins due to the pres- 
ence of multiple genes with independent promoters, neu- 
rexins are subject to extensive alternative splicing that 
could potentially generate a large number of cell surface 
proteins (Ushkaryov et al., 1992). It is unclear as to how 
many proteins are specified because the number of alter- 
natively spliced sequences in the different neurexins are 
unknown, as are the number of insert variants at each 
site and the independence of alternative splicing events at 
different sites. To address these questions, two strategies 
were pursued. First, a large number of cDNA clones en- 
coding bovine neurexin la were examined to assess the 
independence of alternative splicing events and the rela- 
tive frequency of different ypes of variants. Bovine cDNAs 
were examined instead of rat cDNAs to evaluate the evolu- 
tionary conservation of alternative splicing. Second, poly- 
merase chain reaction (PCR) analyses were performed on 
Neurexin Cartography of Rat Brain 
501 
F 
2~ 
::;'11" 5 
,Z  , 
Glom.  
EPL 
MCL 
GCL 
Glom. 
EPL 
MCL 
GeL 
Figure 4. Distribution of Neurexins in Olfac- 
tory Bulb 
(a) shows a bright-field micrograph of a thionin- 
stained section, and (b)-(k) show dark-field mi- 
crographs of corresponding sections from 
adult rat olfactory bulbs hybridized with differ- 
ent oligonucleotide probes. Probes used were 
synapsin (b), all neurexins (c), neurexin let (d), 
neurexin I~ (e), neurexin I1~ with a 100-fold ex- 
cess of unlabeled probe (f), neurexin Ik((g), 
neurexin 116 (h), neurexin IIIct (j), and neurexin 
11113 (k). The layers of the olfactory bulb are iden- 
tified on the right (Glom., glomerular layer; 
EPL, external plexiform layer; MCL, mitral cell 
layer; GCL, granular cell layer). Note that each 
neurexin exhibits a different labeling pattern 
between neurons in the olfactory bulb such that 
all types of neurons in the bulb express a differ- 
ent combination of neurexins. 
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Figure 5. Analysis of the Alternative Splicing of Bovine Neurexin I(z 
by cDNA Cloning 
The diagram shows the structures and alternative splicing patterns of 
47 independent cDNA clones. The structure of the bovine neurexin 
I~ mRNA is shown on top of the graph together with the locations of 
rat brain RNA for all potential splice sites, to determine 
whether all neurexins are alternatively spliced at equiva- 
lent positions and to estimate the number of insert variants. 
A bovine cortex cDNA library was screened with a ran- 
domly labeled probe encompassing the coding region of 
neurexin kz. Sequencing and restriction enzyme mapping 
of 102 cDNA clones revealed that 87 encoded neurexin 
la, comprising 47 independent isolates. The remaining 15 
clones either encoded neurexin 113 (4 clones) or were not 
identified (11 clones). The splice site inserts of all cDNA 
clones were determined by restriction enzyme mapping, 
sequencing, and PCR (Figu re 5). Together, the character- 
ization of the bovine cDNAs allowed three conclusions. 
First, the primary sequence of neurexin I(~ is highly con- 
served evolutionarily. There are only 21 amino acid 
changes in the primary sequence between rat and cow; 
3 of these are in the signal peptide and only 1 (at position 
193) is nonconservative. This translates into a 99% con- 
servation for this 1514 amino acid protein. The sequence 
conservation also includes the sequences of splice site 
inserts (see below). 
Second, all of the five sites of alternative splicing pre- 
the five alternatively spliced sequences (1-5) and of restriction enzyme 
sites (Bg, Bglll; K, Kpnl; P, Pstl). For each alternatively spliced se- 
quence in a given cDNA clone, the insert variant is indicated by letters. 
The terminology for alternatively spliced sequences 1-3 is explained 
in Table 1; for spliced sequences 4 and 5, variant A contains the insert 
and variant B lacks it. Clones 36a, 47a, and 124a were sequenced 
entirely to determ ine the primary structure of bovine neurexin I(~ (Gen- 
Bank accession #L14855). 
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Table 1. Splice Variants of Splice Sites 1-3 of Neurexins 
Variant Sequence cDNA PCR 
Splice site 1 
A 
B 
C 
D 
E 
F 
G 
I1~ 
A 
B 
C 
ilkx 
A 
B 
C 
D 
E 
F 
Splice site 2 
hz 
A 
B 
C 
Ihz 
A 
B 
C 
II1~ 
Splice site 3 
A 
B 
lie 
A 
B 
C 
Ilhz 
A 
B 
CSQEDNNVEGLAHLMMGDQGKSKEDNNVEGLAHLMMGDQ . . . .  GKE 
CSQEDNNVEGLAHLMMGDQGKSKEDNNVEGLAHLMMGDQ . . . .  GKE 
CSQEDNNVEGLAHLMMGDQGKSK . . . . . . . . . . . . . . . . . . . .  GKE 
CSQ-DNNVEGLAHLMMGDQGKSK . . . . . . . . . . . . . . . . . . . .  GKE 
CSQEDNNVEGLAHLMMGDQ . . . . . . . . . . . . . . . . . . . . . . . .  GKE 
CSQ-DNNVEGLAHLMMGDQ . . . . . . . . . . . . . . . . . .  . . . . . .  GKE 
CSQEDNNVE . . . . . . . . . .  GKSK . . . . . . . . . . . . . . . . . . . .  GKE 
CSQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  GKE 
CSEEEHPMEGPAHLTLNSEVGSLLFSEGGAGRGGAGNVHQPTKGKE 
CSEEEHPMEGPAHLTLNSEVGSLLFSEGGAGRGGAGNVHQPTKGKE 
CSEEEHPME . . . . . . . . . .  VGSLLFSEGGAGRGGAGDVHQPTKGKE 
CSEEEHPME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  GKE 
CSEDVSQGPGLSHLMMSEQGRSK . . . . . . . . . . . . . . . . . . . .  ARE 
CSEDVSQGPGLSHLMMSEQGRSK . . . . . . . . . . . . . . . . . . . .  ARE 
CSEDVSQGPGLSHLMMSEQ . . . . . . . . . . . . . . . . . . . . . . . .  ARE 
CSE . . . . . .  GLSHLMMSEQGRSK . . . . . . . . . . . . . . . . . . . .  ARE 
CSE . . . . . .  GLSHLMMSEQ . . . . . . . . . . . . . . . . . . . . . . . .  ARE 
CSEDVSQGP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ARE 
CSE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ARE 
WHDVKVTRNLRQHSGIGHAMVNKLHCSVTISVLTTTGYT 
WHDVKVTRNLRQHSGIGHAMVNKLHCSVTISVLTTTGYT 
WHDVKVTRNLRQHSGIGHAM . . . . . . .  VTISVLTTTGYT 
WHDVKVTRNLRQ . . . . . . . . . . . . . . .  VT ISVLTTTGYT 
WHDVRVTRNLRQHAGIGHAMVNKLHYLVTISVLTTTGYT 
WHDVRVTRNLRQHAGIGHAMVNKLHYLVTISVLTTTGYT 
WHDVRVTRNLRQHAGIGHAM . . . . . . .  VT ISVLTTTGYT 
WHDVRVTRNLRQ . . . . . . . . . . . . . . .  VT ISVLTTTGYT 
WHDVKVTRNLRQ . . . . . . . . . . . . . . .  VT ISVLTTTGYT 
ELDAGRVKLTVNLDClRINCNSS---KGPETLFAGYNLN 
ELDAGRVKLTVNLDClRINCNSS---KGPETLFAGYNLN 
ELDAGRVKLTVNL . . . . . . . . .  G- - -KGPETLFAGYNLN 
ELDGGQMKLTVNLDCLRVGCAPSAAAKGPETLFAGHKLN 
ELDGGQMKLTVNLDCLRVGCAPSAAAKGPETLFAGHKLN 
ELDGGQMKLTVNLDCLRVGCAPT---KGPETLFAGHKLN 
ELDGGQMKLTVNL . . . . . . . . .  G- - -KGPETLFAGHKLN 
ELDGGRVKLMVNLDClRINCNSS---KGPETLYAGQKLN 
ELDGGRVKLMVNLDCIRINCNSS---KGPETLYAGQKLN 
ELDGGRVKLMVNL . . . . . . . . .  G- - -KGPETLYAGQKLN 
+ 
+ + 
+ 
+ + 
+ 
+ 
+ + 
-I- 
-I- 
-I- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ + 
+ 
+ + 
+ + 
+ -I- 
+ + 
+ -I- 
+ + 
+ 
-h -t- 
+ + 
Sequences are named on the left, and their method of identification is indicated on the right. Sequences are shown in single-letter amino acid 
code, with gaps as hyphens. All sequences were from rat brain cDNAs and PCRs except for the site 1 variants for neurexin hz, which were from 
bovine cDNAs (all variants), and rat cDNAs and PCRs (variants B, C, D, and G). At each splice site, comparison of the sequences of different 
insert variants suggests the presence of exchangeable modules that are either present or absent (e.g., F_JDNNVE/GLAHLMMGDQ/GKSK in splice 
site 1 of neurexin I~). Since it seems likely that these different modules occur in more combinations than observed in the limited sample analyzed, 
the total number of variants is probably much larger than is shown here. 
viously observed for rat neurexin Ic~ (Ushkaryov et al., 
1992) are also present in bovine neurexin I~, with an al- 
most complete conservation of the alternatively spliced 
coding sequences. Sequencing of the splice sites of the 
bovine cDNAs revealed that the number of alternatively 
spliced insert variants at splice site 1 is much larger than 
was previously known (listed together with the sequences 
obtained by PCR in Table 1). Some of these inserts have 
an unusual structure. For example, insert variant A con- 
tains a duplication of the same amino acid sequence inter- 
rupted by 4 amino acids. A total of seven different inserts 
were sequenced for splice site 1. Comparison of these 
inserts suggests that they consist of independently in- 
cluded or excluded sequence modules (e.g., the E at the 
beginning or the GKSK in the middle of the insert; Table 
1). If these sequence modules were truly independent of 
each other, at least 63 different insert combinations could 
be generated for splice site 1 of neurexin I~. 
Third, the different splice sites seem to be inserted or 
deleted independently of each other. Of the 47 cDNA 
clones, 15 clones contain all five splice sites and exhibit 
ten different splice site patterns over the five sites. Only 
three splice site patterns were observed twice, and one 
splice site pattern was found in 3 independent cDNA 
clones (Figure 5). In this sample, some variants occu r more 
frequently than others. For example, at splice site 1, 5 
variants (A, C, D, E, and F) were observed only once, 
whereas variant G was observed 5 times and variant B 
was observed 10 times (see Table 1 for definition of these 
variants). Similarly, at splice site 3, variant A was observed 
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Figure 6. Analysis of Alternative Splicing by PCR: Alternatively 
Spliced Sequence 1 of Neurexin I1• as a Representative Example 
PCRs were performed in duplicates on first-strand rat cDNAs with 
either one of the two oligonucleotide primers labeled. Products were 
analyzed on denaturing SDS gels and visualized by autoradiography. 
No detectable neurexin Ila mRNA is present in PC12 cells, in 
agreement with previous RNA blotting data (Ushkaryov et al., 1992). 
29 times and variant B was observed 16 times (Figure 5). 
Together, these observations suggest that certain inserts 
are preferred but that, on the whole, the different splice 
sites are used independently of each other and occur in 
all combinations. 
PCR Analysis of Neurexin Splicing in Rat Brain 
Five sites of alternative splicing are observed in different 
neurexins, of which alternatively spliced sequences 1-3 
are specific for ~-neurexins, and sequences 4 and 5 are 
present in ~- and 13-neurexins (Figure 1). Previous cloning 
and PCR experiments demonstrated that sites 4 and 5 
are present in neurexins I, II, and III (Ushkaryov et al., 
1992, 1994; Ushkaryov and SLidhof, 1993). However, 
these experiments did not reveal whether sites of alterna- 
tive splicing 1, 2, and 3 are present in all neurexins and 
how many insert variants can be used at each site. There- 
fore, we used PCR to determine how many alternatively 
spliced sequences are conserved in all neurexins, how 
complex the alternative splicing is at each position, and 
how similar the sequence inserts are between different 
neurexins. 
PCR reactions were performed on first-strand rat brain 
cDNA with primers specific for the respective neurexin 
and putative splice site studied. Three procedures were 
used to evaluate the PCR products and to guard against 
potential artifacts. First, PCRs were performed in duplicate 
in which one or the other of the two primers was labeled 
with 32p (Figure 6). PCR products were separated on dena- 
turing polyacrylamide g ls and visualized by autoradiogra- 
phy. The separate labeling of each oligonucleotide allows 
direct visualization of specific products, and the denatur- 
ing electrophoresis avoids artifacts due to heteroduplex 
formation (Zorn and Krieg, 1991). Second, PCRs were per- 
formed with unlabeled olJgonucleotides and analyzed by 
denaturing polyacrylamide gel electrophoresis and South- 
ern blotting using internal oligonucleotide probes, thereby 
ensuring that the products observed contain the correct 
insert sequence. Third, PCR products were directly ana- 
lyzed by sequencing. Together, these procedures allow 
a definitive identification of alternative splicing events as 
opposed to aberrant PCR reactions. 
An example of an experiment demonstrating alternative 
splicing at site 1 of neurexin Ila is shown in Figure 6. In 
separate reactions, either one of the two oligonucleotide 
primers was 32P-labeled. Three reaction products were ob- 
served which upon sequencing were found to correspond 
to the 3 insert variants defined by cDNA cloning (Table 
1). Three rat brain regions and PC12 cells were analyzed 
separately. The utilization of alternatively spliced se- 
quences differed between them (see also below). Using 
a similar analysis, we investigated the alternatively spliced 
sequences 1, 2, and 3 of all three e-neurexins. These ex- 
periments showed that all neurexins are alternatively 
spliced at sites 1 and 3, and that neurexins I and II but 
not III are also alternatively spliced at site 2. Sequencing 
of the PCR products confirmed and extended the prior 
cDNA cloning results, allowing us to postulate a list of 
insert sequences for splice sites 1-3 for the different neu- 
rexins (Table 1). Although we attempted to sequence as 
many PCR products as possible, the larger and less abun- 
dant products proved elusive. Accordingly, the insert vari- 
ants whose sequences have been determined represent 
the minimal number of variants. Based on the PCR pat- 
tern, it seems probable that there are many additional vari- 
ants. The sequences of the splice site variants also re- 
vealed that the insert sequences are conserved between 
different neurexins for most sites (Table 1). 
Although PCRs across most sites of alternative splicing 
revealed a limited number of sequence variants, analysis 
of the alternatively spliced sequence 1 of neurexin le gave 
a surprising result: more than 30 different reaction prod- 
ucts were observed (Figure 7). Southern blotting of the 
PCR products with multiple internal o igonucleotides con- 
firmed that the observed products are specific. The modu- 
lar design of the insert sequences for splice site 1 of neu- 
rexin la suggests 63 possible combinations, many of which 
would have identical sizes. Southern blotting with specific 
oligonucleotides that only hybridize to certain insert com- 
binations showed that a subset of the more than 30 total 
products observed for splice site 1 of neurexin I~ contains 
each of the different junctional sequences, as would be 
expected if these products were generated by modular 
combinations of different insert sequences (Figure 7). 
The data presented indicate that neurexins are subject 
to extensive alternative splicing at similar positions in their 
mRNAs. The question arises whether this splicing repre- 
sents a baroque accident of nature or is physiologically 
relevant. To address this question, we investigated 
whether alternative splicing of neurexins is regulated. This 
was studied by probing the expression of splice variants in 
different brain regions. The data shown in Figu re 6 indicate 
that the splice site pattern is not uniform between different 
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Figure 7. PCR Analysis of the Variants of 
Splice Site 1 of Neurexin la 
PCR was performed with e oligonucleotide 
primers identified as 1 and 2 in the bottom dia- 
gram. Reaction products were analyzed by de- 
naturing gel electrophoresis and Southern blot- 
ting with the oligonucleotides A to E that do not 
overlap with the PCR oligonucleotides. The top 
five lanes show autoradiograms of the South- 
ern blot analysis of the PCR reactions with the 
different oligonucleotide probes whose relative 
positions are diagrammed below. In the bottom 
diagram, the top bar depicts the largest insert 
found in a cDNA clone in splice sequence 1 
(variant A in Table 1), with the insert divided 
into five modular sequence blocks. Oligonucle- 
otides C, D, and E were designed to test the 
3 possible combinations of the modular se- 
quences in the insert shown in the bottom 3 
bars. On the autoradiograms on top, the bands 
visualized by the different oligonucleotide 
probes are identified by numbers on the left of 
each gel strip. Note that the number of specific 
PCR products observed far exceeds those pre- 
dicted from a modular use of the sequence of 
the known splice site variants, suggesting the 
presence of additional as yet unidentified alter- 
natively spliced sequences at this position. Mo- 
lecular weight markers are indicated on the 
right (numbers are in base pairs). 
brain regions. In this case, cerebellum contained much 
higher levels of the splice variants lacking part or all of 
the insert than did the rest of the brain. Similar observa- 
tions were made for some but not all of the splice sites. 
Representative examples are shown for splice sites 1,3, 
and 5 of neurexin III (Figure 8). This figure illustrates that 
splice site patterns can differ dramatically between differ- 
ent brain regions, revealing a selective expression of cer- 
tain types of inserts in restricted types of neurons. These 
results indicate that not only neurexin isoform expression 
but also alternative splicing of neurexins is regulated. 
Genomic  Bas is  o f  A l te rnat ive  Sp l i c ing  
To investigate the genomic basis of the alternative splicing 
of the neurexins, part of the neurexin Ila gene was studied 
(Figure 9). Sequencing of the region of the gene corre- 
sponding to splice site 3 revealed the presence of a mini- 
exon that was separated from the preceding exon by a 
160 - -  201 - -  
147-  1 ~ -  
110 - -  147 - -  
................... v~ - -  
76 I 
400- -  
117 - -  
A B C 
Figure 8. Differential Expression of Alternatively Spliced Sequences in Rat Brain 
PCRs were performed on first-strand cDNA from the indicated brain regions with 32P-labeled oligonucleotide primers specific for alternatively 
spliced sequences 1 (A), 3 (13), and 5 (C) of neurexin Ilia. Samples were analyzed by enaturing electrophoresis in a 5% polyacrylamide gel 
followed by autoradiography. Numbers on the left of each panel show the positions and sizes of DNA markers (in base pairs). 
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Figure 9. Structure of Neurexin Ila GeJle Encoding Splice Site 3 
On top, the intron-exon organization ofthe part of the neurexin IIgene from mouse that encodes the sequences urrounding splice site 3 is shown 
(see Table 1). £xonic sequences are shown in boldface capital etters and are translated below the sequence. Splice site donor and acceptor 
sequences are shown in lower-case letters. The approximate sizes of the two introns in this region (6.6 and 1.2 kb) are indicated above the introns. 
Alternative splicing at these positions consists of a combination oftwo mechanisms: first, alternative use of the mini-exon encoding the sequence 
DCLRVGCAP, and second, alternative use of two overlapping splice acceptor sites. The part of the second splice acceptor site that is already in 
the exon if the first site is used is underlined on the right. The combination ofthe two different mechanisms could potentially result in 4 different 
sequence variants at this site, 3 of which were observed experimentally (Table 1). 
rather large intron (6.6 kb). The PCR and cDNA cloning 
results suggest that this mini-exon is alternatively spliced 
in and out of the mRNA (Table 1). For the exon following 
the mini-exon, two possible splice acceptor sites could 
be detected, one with an imperfect consensus sequence 
(....cccccttg) followed by an overlapping perfect consen- 
sus splice acceptor site( ..... cccccttggtgctgcag). Compari- 
son of the translated sequences starting from these 
boundaries reveals that they match exactly the variants 
observed experimentally for splice site 3 (Table 1). Thus, 
at this position alternative splicing involves a combination 
of two mechanisms at the same site, the use of alternative 
exons and of differential splice acceptor sites. This could 
potentially result in 4 variants (Figure 9), 3 of which were 
observed in our clones and PCRs. 
Discussion 
Neurexins are highly polymorphic, brain-specific proteins 
that resemble cell surface receptors. We earlier hypothe- 
sized that the diversity of neurexins imparts specific cell 
surface properties upon neurons, one of which may be 
differential cell-cell recognition (Ushkaryov et al., 1992). 
In the cu rrent study, we have attempted to test two corollar- 
ies of this hypothesis. First, neurexins and their splice vari- 
ants must not be uniformly distributed for this hypothesis 
to be valid, because a random distribution of diverse neu- 
rexins would have no information content. Second, in view 
of the complexity of neurons and synapses, a molecule 
that specifies neuronal interactions hould occur in many 
independent forms. We have now shown that the six princi- 
pal neurexins are differentially distributed in brain, sug- 
gesting that they occur in specific combinations in different 
neurons. This complexity is amplified by the large number 
of splice forms for each isoform, which themselves are 
at least partially differentially distributed in brain. Thus, 
neurexins have the requisite diversity to serve as identifi- 
cation markers on neurons. 
Two approaches were used to investigate the distribu- 
tion of neurexin isoforms in brain. First, an extensive in 
situ hybridization study determined the regions and cells 
in which the six principal neurexins are expressed. The 
results demonstrate that neurexin isoforms are specific for 
neurons and that all classes of neurons express multiple 
neurexins. The expression of the six neurexin isoforms is 
independently regulated, and each exhibits a differential 
distribution. Neurexins la, 1113, and 11113 were found to be 
more widely distributed than neurexins 113, II~, and 1114, 
which tended to be highly expressed only in selected cell 
types. In all brain regions studied, each type of neuron had 
a distinct pattern of neurexin coexpression, supporting the 
notion that the combinatorial expression of neurexins is 
a regulated property of neurons. 
In a second approach, PCR experiments were per- 
formed for alternatively spliced neurexin sequences with 
RNA from different brain regions. In such experiments, 
the ratios of insert variants at each splice site exhibited 
distinct changes between different, rather large brain re- 
gions. This suggests that not only the expression of the 
six principal neurexins but also their alternative splicing 
varies between different brain regions. Thus, neurexins 
exhibit a differential, nonrandom expression in brain that 
at least partially extends to their alternative splicing. 
The number of neurexins was also investigated by two 
methods. First, by cloning a large random collection of 
bovine cDNAs encoding neurexin la, we established the 
evolutionary conservation of neurexin la and its alternative 
splicing, and we demonstrated that the different alterna- 
tive splicing events are independent of each other. Sec- 
ond, using PCR on rat brain cDNA, we showed that, with 
one exception (splice site 2 in neurexin Ill), all splice sites 
are uniformly present in all ~-neurexins. Accordingly, there 
is not only an evolutionary conservation of alternative 
splicing between species but also a conservation of splice 
sites between neurexins, suggesting that alternative splic- 
ing is a property intrinsic to the functions of neurexins. 
Furthermore, the sequences of the different splice inserts 
in different neurexins at any splice site are highly homolo- 
gous to each other. In summary, although the neurexins 
exhibit significant sequence differences that are evolution- 
arily conserved, they display a marked uniformity with re- 
gard to generating multiple forms: all neurexin genes ap- 
pear to have dual promoters, and with one exception all 
neurexin transcripts are extensively alternatively spliced 
at identical positions. 
How many different neurexins are there? If one assumes 
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Figure 10. Overview of the Alternative Splicing of Neurexins 
The six principal forms of neurexins are schematically represented 
with the regions shared between ~- and I~-neurexins shown in a cross- 
hatched pattern. For each alternatively spliced sequence, the number 
of sequenced variants is indicated above its sequence position, and 
the likely number of total variants is given in parentheses. On the right, 
the total number of distinct isoforms are indicated, calculated on the 
basis of the assumption that splice sites are used independently: The 
numbers without parentheses give the total number of isoforms for a 
neurexin based on the observed sequence variants, and the numbers 
in parentheses give the numbers of isoforms based on the potential 
number of variants at each spliced sequence. 
that all splice sites are independent of each other, as sug- 
gested by the cDNA cloning experiments, and if one 
counts only splice variants that have actually been se- 
quenced, the minimum number of different proteins would 
be close to 600 (Figure 10), On the other hand, if the modu- 
lar elements of each splice site insert sequence allowed 
further variations, as suggested by the presence of un- 
characterized specific products observed in the PCR ex- 
periments (Figure 7), there could be more than 3000 dis- 
tinct neurexins generated by the splice sites in the 
currently known genes. Even the lesser of these two esti- 
mates suggests an unprecedented iversity of cell surface 
variants generated by alternative splicing. No other known 
protein family except for the odorant receptors in the nasal 
mucosa and antigen recognition molecules in the immune 
system has a similar diversity. 
The structures of neurexins suggest functions as cell 
surface receptors. If the baroque alternative splicing of 
the neurexins has a functional role, this would most likely 
involve the specification of ligand interactions. Three of 
the alternative splice sites (sites 2, 3, and 4; Figure 1) 
interrupt repeats homologous to the laminin A and agrin 
repeats, and two of them are between domains (splice 
sites 1 and 5). If the laminin A-l ike repeats in neurexins 
are involved in binding to cell surface receptors, as has 
been suggested for the corresponding domains of laminin 
A (Gehlsen et al., 1992), their interruption would be ex- 
pected to have an effect on this binding. The presence in 
brain of hundreds of different neurexins would give ample 
opportunity to confer specificity upon neurons by the ex- 
pression of selected forms. Specificity would require a 
large number of specific ligands for the neurexins either 
belonging to separate protein families or themselves regu- 
lated by alternative splicing. A search for such ligands is 
currently under way. 
Experimental Procedures 
Bovine cDNA Cloning and Characterization 
Approximately 2.5 million plaques of a size-selected amplified cDNA 
library from bovine brain cortex (gift of Dr. J. Dixon, Merck, Sharp, 
and Dohme) were screened with a randomly 32P-labeled DNA probe 
encompassing the entire coding region of rat neurexin la (Ushkaryov 
et al., 1992). Of 150 hybridization-positive plaques identified, 102 were 
plaque purified, excised as plasmids, and evaluated by restriction en- 
zyme mapping, Southern blotting, and DNA sequencing. Of the 102 
original isolates, 87 encoded neursxin la, 4 encoded neurexin I1~, and 
the remaining clones encoded either other neurexins or nonhomolo- 
gous unidentified proteins. The 87 neurexin IQ clones contained sev- 
eral identical isolates, resulting in a total of 49 unique clones (Figure 
5). Inserts in splice site 1 (Figure 1) were sequenced in all clones; 
inserts in site 2 were either sequenced or determined by PCR; inserts 
in sites 3 and 4 were assessed by restriction enzyme digests with 
enzymes whose ability to cut the DNA depended on the presence or 
absence of the insert. In addition, in all clones site 5 (and in some 
clones site 4 as well) was investigated by Southern blotting using splice 
variant-specific oligonucleotides. Only 3 cDNA clones (36a, 47a, 124a) 
were fully sequenced. DNA sequencing was performed with an 
ABI370A DNA sequencer using fluorescently labeled primers and Taq 
polymerase. 
Genomic Cloning 
Genomic clones containing parts of the neurexin II gene were isolated 
from murine ~ and cosmid libraries (obtained from Stratagene) using 
standard procedures (S~dhof et aL, 1985). 
Polymerase Chain Reaction 
PCRs were performed on single-stranded rat brain cDNA synthesized 
on total RNA from different brain regions and PC12 cells (Ushkaryov 
and S0dhof, 1993). Single-stranded cDNA was synthesized on 10-20 
~g of total RNA in a standard reverse transcriptase reaction primed 
by oligo(dT). PCRs were performed using ~P-labeled and/or unlabeled 
primers. A typical PCR mixture contained in 25 ~1:1-3 pl of cDNA 
template, 1 x PCR buffer (Promega), 2 mM MgCI2, 1 p.I of each primer 
(diluted to 50D2eo), and 0.3 pl of Taq polymerase (Cetus). PCRs were 
run for 25-40 cycles of 30 s at 95°C, 30 s at 60°C, and 1-2 min at 
72°C. For analysis of PCR products by electrophoresis, 1 ~.1 of PCR 
reaction mix was boiled for 5 rain with 15 pl of formamide dye (95% 
formamide, 10 mM EDTA, 0.02% bromophenol blue, 0.02% Xylene 
Cyanol FF) and immediately loaded on a 5% polyacrylamide minigel 
containing 8 M urea. Gels were fixed, dried, and exposed to film. For 
nonradioactive PCR primers, gels were electroblotted onto positively 
charged nylon membranes, and bands were visualized by hybridiza- 
tion. For sequencing, PCR products were isolated on 5% gels and 
subcloned into the appropriate M13 vectors. 
In Situ Hybridizations 
Adult Fisher rats (2-4 months) were anesthetized with halothane and 
killed. Brains were frozen on a flat block of dry ice covered with alumi- 
num foil, wrapped in parafilm, and stored air-tight at -80°C until use. 
Frozen sections were cut at a thickness of 15 pm for film autoradiogra- 
phy and 10 I~m for emulsion autoradiography and thaw-mounted on 
RNase-free poly-Lqysine-coated slides. Immediately after sectioning, 
slides were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 10 rain 
and acetylated (Gerfen et al., 1992), followed by two 5 min delipidiz- 
ations in chloroform. Air-dried slides were stored desiccated at -25°C 
until processing. Oligonucleotides were 3' end-labeled with [a-35S]dATP 
(DuPont) using calf thymus terminal transferase (Boehringer) and puri- 
fied byethanol precipitation. Probes were stabilized with dithiothreitol, 
diluted to a final concentration of 1 p.g/ml (106 cpm/I) in hybridization 
buffer (40% or 50% formamide, 5 x SSC, 25 mM sodium phosphate 
buffer [pH 7.0], 1 mM sodium pyrophosphate, 5 x Denhardt's olution, 
0.2 mg/ml alkali-cleaved salmon sperm DNA [Sigma], 0.1 mg/ml polya- 
denylic acid [Boehringer]), and applied to dry slides. Controls con- 
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taining a 50- or 100-fold excess of unlabeled oligonucleotides to com- 
pete out specific binding sites were included in all hybridizations. 
Hybridizations were performed in a chamber with 5 × SSC, 500/0 for- 
mamide as a humidifying buffer for 12-16 hr at 42°C. After hybridiza- 
tion, slides were washed (Gerfen et al., 1992) in 1 x SSC at 60°C, 
dehydrated in ethanol, air dried, and exposed to Amersham Hyperfilm 
beta-max for 3 days to 8 weeks depending on the probe used for the 
experiment. For emulsion autoradiography, dried slides were coated 
with Kodak NTB-2 autoradiography emulsion under Kodak safelight 
filter #2, dried in the dark for 2 hr, and exposed in light-tight containers 
at 4°C for 1-4 months. Slides were developed at 14°C in Kodak D19, 
fixed in cold Kodak Rapid fixer, and photographed using microscopes 
equipped for bright- and dark-field viewing. The oligonucleotides used 
had the following sequences (all are antisense probes except where 
specifically noted): Pan-neurexin probes, GGAGATCTAGTTGCGGT- 
ACTTGTACATGG CGTAGAGGAGGAT, GTACTTGTACATGGCAT- 
ACAGAGGATAAGGATGCAGAG, and GTTTCGGTACTTGTACAT- 
GGCGTAGAGAAGGAT; neurexin h:{, TCCAC'I-I-GGGGAAGCGCGT- 
CCACTGGCCCTCAGCGCCTGGGAACTC; neurexin Io sense probe, 
GAGTTCCCAGG CGCTGAGGGCCAGTGGACGCGCTTCCCCAAG- 
TGGA; neurexin li3, ATCCCAGCTCGGCACCGCACCGGAGCATCC- 
TCTGGTACATGGC and CACTCCTAGGAGGCCGCTGAGGGTGAG- 
CGGGACTATCCAGA; neurexin I1(1, CCAGCGCGCGTAGCGAGCC- 
GACTGCCCGGGGCCGCCGCCAA and GAAAGGCGGCTCGTAC- 
TTGACGGTGCTGAGCGTGAGCGCA; neurexin 1113, CGCGGGCAC- 
CCCCCTGCCCGCTCCCCCCGGGGGGCATCTC and CCGCTGCG- 
GGTGAGGAAGGGCATGCGGTTGATGGCGAT; neurexin II1~, CAG- 
CGTAGATAGCGGGCCCACTGGTTAGGGAGGCCCATGAAC and 
CAAATACAG GAG CAGCC CAG TGGAAACA TTG GTCI-r'GAAC; neu- 
rexin IIIJ3, CAAGTGTTTCCCTCTCCCCAGCCTCCAGACATCGGAT- 
CATGTA; synapsin land II, CCAGTCGGTGTGCGGCTCGTCGATTA- 
CCAGCAGCACCCTGGC. 
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